Introduction: Pompe disease is a progressive and debilitating autossomal recessive myopathy due to mutations in lysossomal acid-alpha-glucosidase. Its late-onset form has a heterogeneous presentation mimicking other neuromuscular diseases, leading to diagnostic challenge. Objective: To develop consensus based recommendations for the diagnosis of late-onset Pompe Disease. Material and Methods: Bibliographic review and analysis of an opinion questionnaire applied to a group of specialists with expertise in the diagnosis of several myopathies and lysossomal storage disorders. Discussed in consensus meeting. Recommendations: Patients with a progressive limb-girdle weakness, fatigue, cramps and muscle pain should be evaluated with CK levels, ele...
Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting...
The aim of this study was to search for the frequency of late onset Pompe disease (LOPD) among patie...
Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting...
Introduction: Pompe disease is a progressive and debilitating autossomal recessive myopathy due to m...
This consensus statement by a panel of neurology experts aimed to provide a practical and implementa...
Pompe disease is an autosomal-recessive lysosomal storage disorder characterized by progressive myop...
Pompe disease is an autosomal-recessive lysosomal storage disorder characterized by progressive myop...
Pompe disease is a rare autosomal-recessive disorder characterised by limb-girdle myopathy and respi...
Background: Pompe disease is a rare but potentially treatable metabolic disorder having an estimated...
Objective A multicentre observational study was aimed to assess the prevalence of late-onset Pompe d...
Objective A multicentre observational study was aimed to assess the prevalence of late-onset Pompe d...
<div><p>ABSTRACT Pompe disease is an inherited disease caused by acid alpha-glucosidase (GAA) defici...
A multicentre observational study was aimed to assess the prevalence of late-onset Pompe disease (LO...
Pompe disease (PD) is an autosomal-recessively inherited neuromuscular disease that, if not diagnose...
Introduction. Pompe disease is an autosomal recessively inherited lysosomal storage disorder. It is ...
Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting...
The aim of this study was to search for the frequency of late onset Pompe disease (LOPD) among patie...
Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting...
Introduction: Pompe disease is a progressive and debilitating autossomal recessive myopathy due to m...
This consensus statement by a panel of neurology experts aimed to provide a practical and implementa...
Pompe disease is an autosomal-recessive lysosomal storage disorder characterized by progressive myop...
Pompe disease is an autosomal-recessive lysosomal storage disorder characterized by progressive myop...
Pompe disease is a rare autosomal-recessive disorder characterised by limb-girdle myopathy and respi...
Background: Pompe disease is a rare but potentially treatable metabolic disorder having an estimated...
Objective A multicentre observational study was aimed to assess the prevalence of late-onset Pompe d...
Objective A multicentre observational study was aimed to assess the prevalence of late-onset Pompe d...
<div><p>ABSTRACT Pompe disease is an inherited disease caused by acid alpha-glucosidase (GAA) defici...
A multicentre observational study was aimed to assess the prevalence of late-onset Pompe disease (LO...
Pompe disease (PD) is an autosomal-recessively inherited neuromuscular disease that, if not diagnose...
Introduction. Pompe disease is an autosomal recessively inherited lysosomal storage disorder. It is ...
Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting...
The aim of this study was to search for the frequency of late onset Pompe disease (LOPD) among patie...
Pompe disease is a rare metabolic disorder with available enzymatic replacement therapy. Contrasting...